Patent classifications
C
C07
C07H
15/00
C07H15/20
C07H15/24
C07H15/248
C07H15/248
ADJUVANT WITH TLR4 AGONIST ACTIVITY
20230287027
·
2023-09-14
·
·
The present invention relates to a compound useful as vaccine adjuvant, a manufacturing process thereof, a pharmaceutical composition comprising the compound, and use of the compound as vaccine adjuvant.